Mesoblast (MESO) Operating Leases (2019 - 2025)
Mesoblast's (MESO) quarterly Operating Leases came in at $6.3 million in Q2 2025, up 220.85% year-on-year from $2.0 million in Q2 2024, and up 220.85% quarter-over-quarter from $2.0 million in Q2 2024.
Mesoblast (MESO) Operating Leases (2019 - 2025) Analysis & Trends
Mesoblast has disclosed Operating Leases across 7 years of filings, most recently posting $6.3 million for Q2 2025.
- Operating Leases for Q2 2025 came in at $6.3 million, up 220.85% year-over-year; the trailing twelve-month figure through Jun 2025 was $6.3 million (up 220.85% YoY), and the FY2025 annual result was $6.3 million, up 220.85% from the prior year.
- Operating Leases came in at $6.3 million for Q2 2025 at Mesoblast, up from $2.0 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $8.5 million in Q2 2021 to a low of $2.0 million in Q2 2024.
- The 5-year median for Operating Leases is $6.3 million (2025), against an average of $5.5 million.
- Across the five-year window, Operating Leases tumbled 48.17% in 2023 and soared 220.85% in 2025, its largest moves.
- Mesoblast's Operating Leases stood at $8.5 million in 2021, then dropped by 16.5% to $7.1 million in 2022, then plunged by 48.17% to $3.7 million in 2023, then plunged by 46.84% to $2.0 million in 2024, then jumped by 220.85% to $6.3 million in 2025.
- The last three Operating Leases figures came in at $6.3 million (Q2 2025), $2.0 million (Q2 2024), and $3.7 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 6.26 Mn |
| Jun 30, 2024 | 1.95 Mn |
| Jun 30, 2023 | 3.67 Mn |
| Jun 30, 2022 | 7.09 Mn |
| Jun 30, 2021 | 8.49 Mn |
| Jun 30, 2020 | 6.32 Mn |
| Jun 30, 2019 | 5.60 Mn |